MEC Signs RTO Definitive Agreement To Acquire Albert Labs, A European Psychedelic Drug Researcher & Developer Post published:March 5, 2021 Post category:Press Release
Tryp Therapeutics Announces Application to List on OTCQB Post published:March 4, 2021 Post category:Press Release
Silo Pharma, Inc. Enters into an Exclusive Option Agreement with the University of Maryland, Baltimore for patented Homing Peptides Targeting Rheumatoid Arthritis Post published:March 4, 2021 Post category:Press Release
MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAIâ„¢ Post published:March 4, 2021 Post category:Press Release
PsyBio Therapeutics Announces Retention of Market Maker Post published:March 4, 2021 Post category:Press Release
PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board Post published:March 4, 2021 Post category:Press Release
Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research Post published:March 4, 2021 Post category:Press Release
MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury Post published:March 4, 2021 Post category:Press Release
atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round Post published:March 3, 2021 Post category:Press Release
Cybin Inc. Announces Uplisting to OTCQB Venture Market Post published:March 3, 2021 Post category:Press Release